Cdi-988, Snow Mountain Virus
Norovirus
Phase I/II
Not Yet Recruiting
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus
Sep 15, 2025
―
Cc-42344
Influenza A
Phase II
Completed
Influenza Viral Challenge Study of CC-42344 in Healthy Participants
Nov 29, 2023
―
Cdi-988
Healthy Volunteers
Phase I
Completed
CDI-988 Safety Study in Healthy Participants
Jul 28, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Cocrystal Pharma Inc (8CC) have in its pipeline
8CC is currently developing the following drugs: Cdi-988, Snow Mountain Virus, Cc-42344, Cdi-988. These drug candidates are in various stages of clinical development as the company works toward FDA approval.